Series A of €32 million. Regulatory milestones: self-affirmed GRAS status in 2024 and FDA 'No Questions' letter in 2025. Lead investor name not specified in source text.
About Verley
French foodtech startup developing precision-fermented functional whey protein ingredients (beta-lactoglobulin) for B2B food and nutrition manufacturers, marketed under the FermWhey™ range to enable high-protein, clean-label and digestible product formulations with reduced environmental impact.
Lyon, France
Read Company ProfileFrequently Asked Questions
What type of funding round did Verley raise?
Verley raised a series-a round.
How much did Verley raise in its series-a?
Verley raised $32,000,000 EUR in its series-a.
Who invested in Verley's series-a?
The investors in Verley's series-a are: Sofinnova, Sparkfood, Captech, Founders Future, Bpifrance.
How will Verley use the funds from its series-a?
Verley plans to use the funds for: US market entry and commercial deployment, early customer scale-up, ramp-up of production capacities, continued R&D to improve technology performance, efficiency and sustainability.